GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (FRA:7UM0) » Definitions » YoY Rev. per Sh. Growth

Zelluna ASA (FRA:7UM0) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Zelluna ASA's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 0.00%.

Zelluna ASA's Revenue per Share for the three months ended in Mar. 2025 was €0.00.

Zelluna ASA YoY Rev. per Sh. Growth Historical Data

The historical data trend for Zelluna ASA's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA YoY Rev. per Sh. Growth Chart

Zelluna ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zelluna ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zelluna ASA YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Zelluna ASA's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2024 )
=(Revenue per Share (A: Dec. 2024 )-Revenue per Share (A: Dec. 2023 ))/ | Revenue per Share (A: Dec. 2023 ) |
=(0-0)/ | 0 |
=N/A %

Zelluna ASA's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelluna ASA YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Zelluna ASA's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Zelluna ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (FRA:7UM0) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
OSL:ABTEC OSL:ONCIN OSL:SOFTX OSL:EXTX OSL:ABS OSL:BGBIO OSL:PCIB OSL:CRNA OSL:LYTIX OSL:TRMED VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ULTIo:Sweden ZLNA:Norway
Address
Ullernchausseen 64, Oslo, NOR, 0379
Website
https://www.zelluna.com
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.

Zelluna ASA Headlines

No Headlines